GHRL and sarcopenia: Myostatin, thalidomide, OHR/AVR118, celecoxib, VT-122, and anabolic agents such as ghrelin and its analogues, MT-102, BYM338, and ruxolitinib, are other compounds under investigation as sarcopenia therapies.